CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early-and late-onset colorectal cancer

Genes and Immunity

Volumn 12, Issue 8, 2011, Pages 653-662

  Agesen T H ^a,b   Berg, M ^a,b   Clancy, T ^a   Thiis Evensen, E ^a   Cekaite, L ^a,b   Lind, G E ^a,b   Nesland, J M ^a,c   Bakka, A ^d   Mala, T ^e   Hauss, H J ^f   Fetveit, T ^g   Vatn, M H ^a,d   Hovig, E ^a,b   Nesbakken, A ^b,c,e   Lothe, R A ^a,b,c   Skotheim, R I ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f SØRLANDET HOSPITAL   (Norway)

^g Section for Gastroenterology   (Norway)

Author keywords

colorectal neoplasm; early onset of disease; gene expression microarray; genetic predisposition; hereditary cancer

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; HISTONE H3;

ADULT; AGED; ARTICLE; BIOSTATISTICS; CANCER PATIENT; CHARCOT LEYDEN CRYSTAL GENE; CHROMOSOME BAND; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; GENE; GENE EXPRESSION; GENE LOCATION; GENETIC DISORDER; HUMAN; IFNAR1 GENE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR IMMUNITY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; LYSOPHOSPHOLIPASE; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR, INTERFERON ALPHA-BETA;

EID: 82555174367     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2011.43     Document Type: Article

References (41)

1. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W et al. SEER Cancer Statistics Review, 1975-2007. National Cancer Institute (http://www.seer.cancer. gov/csr/1975-2007/browse-csr.php) 2010.
2. Rustgi AK. The genetics of hereditary colon cancer. Genes Dev 2007; 21: 2525-2538. (Pubitemid 47607664)
3. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004; 4: 769-780. (Pubitemid 39331149)
4. Skoglund J, Djureinovic T, Zhou XL, Vandrovcova J, Renkonen E, Iselius L et al. Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J Med Genet 2006; 43: e7.
5. Blaker H, Mechtersheimer G, Sutter C, Hertkorn C, Kern MA, Rieker RJ et al. Recurrent deletions at 6q in early age of onset non-HNPCC-and non-FAP-associated intestinal carcinomas. Evidence for a novel cancer susceptibility locus at 6q14-q22. Genes Chromosomes Cancer 2008; 47: 159-164.
6. Hong Y, Ho KS, Eu KW, Cheah PY. A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis. Clin Cancer Res 2007; 13: 1107-1114. (Pubitemid 46424049)
7. Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet 2009; 10: 353-358.
8. Berg M, Agesen TH, Thiis-Evensen E, Infac IS, Merok MA, Teixeira MR et al. Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci. Mol Cancer 2010; 9: 100.
9. Koessler T, Oestergaard MZ, Song H, Tyrer J, Perkins B, Dunning AM et al. Common variants in mismatch repair genes and risk of colorectal cancer. Gut 2008; 57: 1097-1101.
10. Giraldez MD, Balaguer F, Caldes T, Sanchez-de-Abajo A, Gomez-Fernandez N, Ruiz-Ponte C et al. Association of MUTYH and MSH6 germline mutations in colorectal cancer patients. Fam Cancer 2009; 8: 525-531.
11. Quackenbush J. Microarray analysis and tumor classification. N Engl J Med 2006; 354: 2463-2472. (Pubitemid 43855049)
12. Perou CM, Sorlie T, Eisen MB, van de RM, Jeffrey SS, Rees CA et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-752.
13. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869-10874. (Pubitemid 32878711)
14. Cardoso J, Boer J, Morreau H, Fodde R. Expression and genomic profiling of colorectal cancer. Biochim Biophys Acta 2007; 1775: 103-137. (Pubitemid 44881195)
15. Chan SK, Griffith OL, Tai IT, Jones SJ. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomarkers Prev 2008; 17: 543-552. (Pubitemid 351469203)
16. De Re V, Simula MP, Cannizzaro R, Pavan A, De Zorzi MA, Toffoli G et al. Galectin-10, eosinophils, and celiac disease. Ann NY Acad Sci 2009; 1173: 357-364.
17. Bracarda S, Eggermont AM, Samuelsson J. Redefining the role of interferon in the treatment of malignant diseases. Eur J Cancer 2010; 46: 284-297.
18. Clancy T, Pedicini M, Castiglione F, Santoni D, Nygaard V, Lavelle TJ et al. Immunological network signatures of cancer progression and survival. BMC Med Genomics 2011; 4: 28.
19. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008; 135: 1079-1099.
20. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85. (Pubitemid 30451850)
21. Dyer KD, Handen JS, Rosenberg HF. The genomic structure of the human Charcot-Leyden crystal protein gene is analogous to those of the galectin genes. Genomics 1997; 40: 217-221. (Pubitemid 27124082)
22. Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer 2005; 5: 29-41. (Pubitemid 40052323)
23. Demetter P, Nagy N, Martin B, Mathieu A, Dumont P, Decaestecker C et al. The galectin family and digestive disease. J Pathol 2008; 215: 1-12. (Pubitemid 351619870)
24. Bracarda S, Eggermont AM, Samuelsson J. Redefining the role of interferon in the treatment of malignant diseases. Eur J Cancer 2010; 46: 284-297.
25. Billiau A. Interferon: the pathways of discovery I. Molecular and cellular aspects. Cytokine Growth Factor Rev 2006; 17: 381-409. (Pubitemid 44574538)
26. Spano JP, Milano G, Rixe C, Fagard R. JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications. Eur J Cancer 2006; 42: 2668-2670. (Pubitemid 44584670)
27. Ferrone C, Dranoff G. Dual roles for immunity in gastrointestinal cancers. J Clin Oncol 2010; 28: 4045-4051.
28. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-1964. (Pubitemid 44498003)
29. Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 2008; 40: 1426-1435.
30. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40: 955-962.
31. Montanaro L, Trere D, Derenzini M. Nucleolus, ribosomes, and cancer. Am J Pathol 2008; 173: 301-310.
32. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310: 644-648. (Pubitemid 41528150)
33. Kerrien S, am-Faruque Y, Aranda B, Bancarz I, Bridge A, Derow C et al. IntAct-open source resource for molecular interaction data. Nucleic Acids Res 2007; 35: D561-D565. (Pubitemid 46056270)
34. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S et al. Human protein reference database-2009 update. Nucleic Acids Res 2009; 37: D767-D772.
35. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res 2006; 34: D535-D539.
36. Bader GD, Betel D, Hogue CW. BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res 2003; 31: 248-250. (Pubitemid 36150376)
37. Jenssen TK, Laegreid A, Komorowski J, Hovig E. A literature network of human genes for high-throughput analysis of gene expression. Nat Genet 2001; 28: 21-28. (Pubitemid 32405811)
38. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550. (Pubitemid 41528093)
39. Karolchik D, Kuhn RM, Baertsch R, Barber GP, Clawson H, Diekhans M et al. The UCSC genome browser database: 2008 update. Nucleic Acids Res 2008; 36: D773-D779. (Pubitemid 351149822)
40. Sarkar D, Falcon S, Gentleman R. Using categories defined by chromosome bands. Bioconductor, version 2.5, http://www. bioconductor.org, 2008.
41. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498-2504. (Pubitemid 37428274)